- CEO
- Mikishi Takamura
- Full Time Employees
- 2,680
- Sector
- Process industries
- Industry
- Chemicals: specialty
- Address
- 1-14-1 Nishi-Shimbashi Tokyo Japan 105-8419
- IPO Date
- May 16, 1949
- Business
- Toagosei Co., Ltd. manufactures and sells a broad range of chemical products, operating through Commodity Chemicals; Polymer & Oligomer; Adhesive Material; Performance Chemicals; Plastics; and Other segments. The company produces commodity chemicals such as liquid caustic soda, liquid chlorine, synthetic hydrochloric acid, sodium hypochlorite, caustic potash, sulfuric acid, sodium sulfite, potassium pyrophosphate, copper oxide, iron perchloride, hypochlorous acid, copper pyrophosphate, copper potassium pyrophosphate, chlorinated solvents including trichloroethylene and tetrachloroethylene, ammonium sulfate, potassium bicarbonate fertilizers, industrial gases like oxygen, nitrogen, argon, hydrogen, carbon dioxide and mixed gases; polymers and oligomers encompassing acrylic acid, acrylic esters, acrylic monomers, acrylamide tertiary butyl sulfonic acid, ethylene carbonate, acrylic polymers including dispersants, thickeners, scale inhibitors, pressure sensitive adhesives, binders, paint vehicles, gelling agents, graft polymers, ARUFON and macromonomers, special polymers, solvent-free acrylic polymers, special acrylic monomers, polymer flocculants and UV-curable resins; adhesive materials such as instant glue (Aron Alpha), functional adhesives, accessories, silsesquioxane derivatives, powder paints; performance chemicals including liquid hydrogen chloride, hexachlorodisilane, potassium hydroxide and carbonate aqueous solutions, ferric chloride solutions, inorganic functional materials for environmental amenity and electronics; and plastics products like piping equipment, nursing care products, elastomeric compounds and environmental preservation systems. Founded in 1944 and headquartered at 1-14-1 Nishi-Shimbashi, Minato-ku, Tokyo, Japan, Toagosei conducts operations in Japan, the United States, China, Taiwan, Hong Kong, India and internationally, serving industries including semiconductors, electronics, automotive, construction, civil engineering and medical. Recent developments include the establishment of a local subsidiary in India in 2024; launch of independent instant adhesive operations in the U.S. in 2025; conclusion of a collaborative research agreement with Innovation Center of NanoMedicine on siRNA medication for triple-negative breast cancer treatment in 2025; endorsement of TNFD recommendations and participation in the TNFD Forum in 2025; announcement of the low-carbon hydrogen model town pilot project in Chita City, Aichi Prefecture in 2025; issuance of unsecured straight bonds in 2025; ongoing treasury stock acquisitions and cancellations to enhance shareholder returns; and participation in land-based salmon farming and low-carbon hydrogen feasibility studies in 2024.